ARCHIVES

Wilding named director, Univ. of Wisconsin Cancer Center.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995

IOM Report Links Agent Orange, CLL

January 24, 2003

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

April 6, 1984

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004